Ozempic, Mounjaro Users Cut $6.5 Billion From Grocery Bills: GLP-1 Boom Triggers Panic In Packaged Food Aisles

Valparaiso,,In,Usa,December,13,,2023:,Ozempic,Pen,And,Box

GLP-1 medications are delivering a $6.5 billion blow to U.S. grocery spending, with weight-loss drugs fundamentally altering consumer food purchasing patterns across America’s retail landscape.

What Happened: Big Chalk Analytics reports that users of glucagon-like peptide-1 receptor agonists, including Novo Nordisk A/S‘s (NYSE:NVO) Ozempic and Wegovy alongside Eli Lilly and Co.‘s (NYSE:LLY) Mounjaro and Zepbound, have significantly reduced their grocery expenditures.